European Cancer Epigenetics Conference 2017

2nd European Cancer Epigenetics Conference 2017

11 – 13 May 2017

DKFZ Heidelberg
Germany

Organizers: Frank Lyko, Christoph Plass, Karsten Rippe, Manon van Engeland & Olaf Witt

Cancer epigenetics is developing into one of the most promising and rapidly developing fields in oncology. It reveals mechanisms by which cancer genes are deregulated, provides novel tumor biomarkers to identify and target the cell of origin of a given tumor, and can be exploited to predict cancer risk. Notably, current large-scale cancer genome sequencing efforts have discovered a surprisingly large number of cancer-specific mutations in regulators of the epigenome. The high relevance of epigenetics for cancer goes hand in hand with the development of an increasing number of epigenetic drugs used in cancer therapy. Inspired by the success of the '1st European Cancer Epigenetics Conference' in Maastricht in 2015, we are inviting researchers to the 2nd symposium to continue exploring this exciting field. The 2017 meeting will be organized into 5 sessions covering the following fields:

- Mechanisms of Epigenetic Deregulation

- Epigenetics of Single Cells and Molecules

- Epigenetic Programming & Epigenetic Plasticity

- Translational Epigenetics

- Epigenetic Therapy

Keynote Speaker

Stephen B. Baylin, Virginia and D. K. Ludwig Professor in Cancer Research; Director, Cancer Biology Program 

Confirmed Speakers

Stephan Beck, University College London, UK
Yehudit Bergman, Hebrew University, Jerusalem, Israel
Christoph Bock, CeMM, Vienna, Austria
Joseph Costello, UCSF, USA
Manel Esteller, IDIBELL Bellvitge Biomedical Research Institute, Barcelona, Spain
Beat Fierz, EPFL, Lausanne, Switzerland
Peter Fraser, Babraham Instiute, Cambridge, UK
François Fuks, Brussels, Belgium
Monika Hegi, Lausanne, Switzerland
James Herman, Pittsburgh, USA
Jean-Pierre Issa, Fels Institute for Cancer Research and Molecular Biology, Philadelphia, USA
David Jones, DKFZ, Heidelberg, Germany
Stefan Knapp, Institute of Pharmaceutical Chemistry, Frankfurt, Germany
Michael Lübbert, Medical Center University of Freiburg, Germany
Iñaki Martín-Subero, Barcelona, Spain
Ana Pombo, MDC, Berlin, Germany
Dirk Schübeler, FMI, Basel, Switzerland

Additional oral presentations will be selected from the submitted abstracts. 

Conference Program

download program (PDF)

Time Schedule
May 11: 13:00 - 21:00 (ending with the Poster Session & Dinner Reception)
May 12: 8:30 - 16:00 (followed by an optional Heidelberg City Tour)
May 13: 9:00 - 12:45 (ending with the Poster & Short Talk Award & Lunch)

Registration and Conference Fees

Registration fee for all participants: 120 Euro until February 28, 2017, 240 Euro until April 15, 2017

Please register here for "participation only" until April 15, 2017. Deadline for abstract submission closed as of Mach 31st.

Contact

For questions contact ecec2017@dkfz.de

Download

to top